Tobin Scientific and PHCBI provided a sustainable solution for Takeda's cold storage needs, setting up a fleet of ultra-low temperature freezers that reduced power consumption by 30%, without compromising preservation performance. This catered to the global demand for energy-efficient preservation equipment in pharmaceutical and life sciences research.
Advances in pharmaceutical and life sciences research continue to increase the global demand for ultra-low temperature freezers. mRNA vaccine research and storage, cell and gene therapy development, pharmaceutical development, and storage of samples for therapeutic advances all require accurate, dependable, and secure preservation equipment. This growth in demand, combined with the need to meet energy efficiency goals set by many industry institutions and governing bodies, has created a need for products that minimize power consumption without compromising preservation capability.
Tobin Scientific partnered with PHCBI to provide Takeda, a leading global pharmaceutical company, with a sustainable solution for their cold storage needs. They provided a fleet of freezers designed to offer high levels of preservation performance while minimizing power consumption. We utilized the HFC-free ultra-low temperature freezers PHCbi ECO SMART series that enable efficient and safe long-term storage of specimens and samples for researchers engaged in drug discovery and life science research.
The partnership yielded impressive results, with a 30% reduction in power consumption achieved, demonstrating that it is possible to meet the growing global demand for ultra-low temperature freezers in a more sustainable manner.